Background: Artemisia pollen allergy is a major cause of asthma in Northern China.
| INTRODUCTION
Over the past 30 years, there has been a significant increase in the prevalence of allergy in the Chinese population, and allergy has been found to be the major factor causing asthma.
1,2 A cross-sectional study has shown that overall, while about 11.3% of patients in China with respiratory allergies are sensitized to Artemisia pollen, this value is much higher in Northern China (>50%). Among the major pollen species causing seasonal allergic asthma in China, Artemisia pollen has the highest association index. [3] [4] [5] [6] [7] The hop (Humulus scandens),
ragweed (Ambrosia artemisiifolia), and goosefoot (Chenopodium album)
pollen seasons overlap with that of Artemisia, but their IgE positive rate was significantly lower in a survey of a large number of ImmunoCAP tests in Beijing. 5 In some areas in Europe, mugwort (A. vulgaris) pollen has also been associated with late summer and autumn hay fever and asthma, but its clinical importance is limited compared to birch and grass pollen. 8 Component-resolved diagnosis (CRD) enables IgE sensitization profiles and potential risk to be established, and whether specific IgE is the result of primary sensitization or cross-reactivity can also be determined. [9] [10] [11] [12] [13] Such information can assist in making the right choice of immunotherapy, particularly when pollen seasons of different allergenic sources overlap. [14] [15] [16] [17] [18] [19] Seven Artemisia pollen allergens have been identified and listed in the IUIS database (www.allergen. org), including the recently added 62 kDa putative galactose oxidase protein (Art an 7), first purified from sweet wormwood (A. annua). 20, 21 In earlier studies with nine patients in Europe, using arraybased profiling of five mugwort allergens, Art v 1, Art v 3, Art v 4, and Art v 6 were recognized by 60%-80% patients, with a co-sensitization frequency of 60% of three of these four allergens. 22 Sensitization to multiple allergens increased risk of allergic asthma allergic asthma %
Sensitized allergen component

G R A P H I C A L A B S T R A C T
The frequency and IgE levels of four Artemisia allergen components in patients from SX and SD were higher than that in YN China.
Patients from SX and SD were more likely to have allergic asthma than patients from YN China. Patients co-sensitization to Art v 1, Artemisia pollen count records (microscopic observation of pollen collected on a slide by a simple device) were taken from a survey report 25 and are given in Figure S1 . 
| ImmunoCAP tests
All 240 subjects were tested for their specific IgE to mugwort pollen extract (code w6) and two commercial components (nArt v 1, nArt v 3, with code w231 and w233, respectively) by ImmunoCAP (ThermoFisher Scientific, Uppsala, Sweden). The two additional natural allergens Art ar 2 (GenBank MF326217) and Art an 7 (GenBank KY428925) recently included in IUIS (http://allergen.org/) were biotinylated and coupled to streptavidin-conjugated ImmunoCAPs (o212) as described previously. 26 Natural Art ar 2 was purified by a monoclonal antibody affinity chromatography (C9-C1: obtained by immunization from a pollen extract of Chinese mugwort A. argyi),
and its primary sequence is identical to Art v 2 as demonstrated upon cloning (GenBank MF326222). Natural Art an 7 was purified from A. annua extract as described previously. 21 Sera with an IgE value > 100 kU A /L were diluted and retested, with 0.35 kU A /L considered as positive cutoff.
| Statistical analyses
Data were analyzed by SPSS 21.0, with a value of P < 0.05 considered as significantly different. Frequencies of positive IgE were analyzed by chi-square test or Fisher's exact test and differences in IgE levels between groups calculated by the Mann-Whitney U test.
The Spearman correlation coefficient analysis was used to determine correlations of IgE levels between groups, and quantitative variables in the three areas were compared by Kruskal-Wallis test, with Bonferoni correction applied in pair-wise comparison.
| RESULTS
| Symptoms and sensitization profiles of Chinese mugwort-allergic patients
Of the 240 patients, the vast majority (95%) were diagnosed with Artemisia pollen-associated allergic rhinitis. In addition, 53% had conjunctivitis, 43% allergic asthma, and 19% atopic eczema, with quite significant geographic variation of these three symptoms (Table 1) .
For IgE reactivity against the four components, Art v 1 was the most frequently recognized allergen (81%, range 53%-93%), ahead of Art an 7 (80%, range 38%-87%), Art v 3 (53%, range 9%-66%) and Art v 2 (42%, range 9%-48%). Median IgE levels were highest against Art v 1 (9.6 kU A /L), followed by Art an 7 (2.1 kU A /L) and Art v 3 (1.1 kU A /L), whereas the median IgE to Art ar 2 was below the cutoff (Table 1 ).
The correlation of mugwort IgE levels to the sum of the four components was very high (Spearman r = 0.92, P < .001), fit- 
| CRD and age
IgE levels against mugwort extract, Art ar 2, and Art an 7 were significantly different (P < 0.05) among children, teenagers and adults ( Figure 1A) , with the adult group having a significantly lower IgE to mugwort and Art an 7 than the child and teenager group. The frequency of sensitization to Art ar 2 was higher in the child group than in the teenager and adult groups ( Figure 1B ). The number of components recognized per patient was not significantly different between age groups ( Figure 1C ).
| CRD and geographic background
The IgE levels against mugwort extract and four allergen components in Shanxi (SX) and Shandong (SD) in Northern China were significantly higher than in patients from Yunnan (YN) in Southwestern China (P ≤ 0.001). SX patients had higher IgE levels against the two compo- were very high in YN patients, followed by SX patients, with the lowest rate found in SD (P < 0.01) ( Figure 2D ).
| CRD and clinical phenotypes
For all tested patients, mugwort extract IgE values in the allergic asthma group were higher than the non asthmatic group but not sig- To exclude the influence of geographic background on association of sensitization profiles and age with allergic asthma, analyses were performed for the 178 patients from SX alone. There were no significant differences between asthmatic and non asthmatic groups for IgE values of mugwort extracts and four individual components (Figure 4A ). There was a weak but significant correlation between patients' age and asthma symptoms (Spearman r = 0.284, P < 0.001),
with adults suffering more often from asthma than children (Table 2 , Figure 4B ). Asthmatic patients had a higher frequency of IgE reactivity to three or four allergens than the non asthmatic patients (0-2 components) (P = 0.001, OR, 2.86, 95% CI, 1.49-5.50) ( Figure 4C ).
The sensitization frequency to Art v 1 (P = 0.027) and Art v 3 (P = 0.01) was significantly higher than in the non asthma group (Table 2) , and more than a 2-fold risk of allergic asthma was found in No significant differences were observed for the other two allergens ( Table 2 ). The interrelation of symptoms and sensitized allergens in asthmatic and non asthmatic groups is shown in Figure 4D ,E, with 
| DISCUSSION
This study provides new insights in mugwort component sensitization and clinical significance in China. From both sensitization frequencies and IgE titers, we can draw a general conclusion that three allergens qualify as major allergens in China: Art v 1, Art v 3, and Art an 7. These results are in line with those from Europe 27 and our immunoblots of three widely recognized allergens in Northern China. 21 Art v 1 and Art an 7 were consistently the most prevalent (more than 80%) in the three areas, indicating that these two allergens are biomarkers of Artemisia pollens inducing allergic reactions.
From the observations obtained from Shanxi and Shandong, we estimate the prevalence of Art v 1 at 84%-93% in Northern China, which is quite similar to that of the mugwort-allergic patients in Europe but higher than in North America. 24, 27 Median Art v 1 IgE value was also similar to those in Northern Europe. Art an 7 was assumed to be in the same allergen group as Art v 60 kDa, which was reported about 20 years ago and has recently been identified as a putative galactose oxidase with a very high rate of sensitization (around 90%). 21 In the present study, the frequency of Art an 7 sensitization was quite similar, at 87% in SX and slightly lower in SD.
The prevalence and degree of sensitization to Art v 3 were quite different in these two areas, with 66% in SX and 25% in SD. Very significant differences with respect to recognition of Art v 3 amongst mugwort-allergic patients have also been reported in Europe. 20 Although the prevalence of 66% in SX is quite similar to that reported in central Europe, 10, 28 IgE levels are much higher. The striking difference between SX and SD is most likely explained by a higher pollen load in SX and possibly by different Artemisia species dominating in the regions. 7, 28 Art ar 2 had the least prevalence (42%-48%) and IgE levels, being close to the 58% for Art v 2 reported in Europe. with very low Artemisia pollen exposure (ratio of the total pollen count in peak month in SX, SD, and YN is 10:6:1, Figure S1 ) and the majority of patients being sensitized to ≤2 allergens, only one in 30 patients had allergic asthma ( Figure 2D ). Sensitization to a higher number of allergens is usually accompanied by a higher IgE level and potential broader cross-reactivity to allergens of pollens from not only Artemisa, but also from other genera in the Asteraceae family, such as Dendranthema, Helianthus, Xanthium, and Ambrosia. Art v 1 was ranked highest in inducing asthma because of its higher prevalence and OR values related to asthma. Art v 3 is the second major allergen, although its prevalence was lower than Art v 1; sensitized patients can have very high IgE levels in Northern China, and allergic reactions due to cross-reactivity to various fruits, peanut, soybean, wheat, sunflower seed have been reported in this study and previously. 16, 30, 31 The four components used are natural proteins, so potential CCD involvement in the IgE binding cannot be excluded for those allergens known to be glycoproteins, that is, Art v 1, Art ar 2, and Art an 7. Art v 3 is a lipid transfer protein and is not glycosylated.
Of the three glycoproteins, the Art ar 2 and Art an 7 carry typical CCD-like N-linked glycans, 21, 29 whereas Art v 1 has O-linked glycans that have also been described to be recognized by IgE of some patients. 32 It can therefore not be excluded that both types of glycan-specific IgE antibodies play a role in recognition of the three allergens. However, we think the role of CCD-specific IgE is quite limited in Chinese patients, as in our recent paper on Art an 7, 21 we tested CCD in 21 patients, and found a low frequency of positivity A small number of sera demonstrated significantly higher IgE binding to mugwort extract than to the sum of IgE responses against the four components tested in the present study ( Figure S2 ). This suggests that for these patients other components are probably relevant. Similar to what was reported earlier, 22 Art v 5 seems to be of minor importance, and ten of these sera were negative for IgE reactivity to rArt an 5. We speculate Art v 4 and Art v 6 are most likely to be the missing components because of their broad cross-reactivity. Most mugwort allergy patients have previously been found to first suffer mild allergic rhinitis symptoms at median age of 27.9 years, with a transition to asthma usually taking about 5 years (median age of 32.6 years), 7 and becoming more common after middle age. In this study, the median age was found to be 23 years for Shanxi Province, showed the total Artemisia spp. pollen count had increased 36%, with the peak lasting 2 weeks longer. 35 This indicates a need to control the growth and spread of Artemisia plants in the wild.
In conclusion, different sensitization patterns and symptoms were observed in mugwort-allergic patients from Northern and Southern China. Sensitization to three or more mugwort allergens resulted in a higher risk of allergic asthma. 
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